IP Library Granted Patent US 10,543,237
Granted Patent B2
US 10,543,237 · App. 16/023,146 · Granted Jan 28, 2020

Bioeffective krill oil compositions

Inventors: Inge Bruheim (Volda, NO); Snorre Tilseth (Bergen, NO); Daniele Mancinelli (Orsta, NO)
Assignee: AKER BIOMARINE ANTARCTIC AS
A61K35/612A23L33/115A61K9/0053A61K9/48A61K9/4825A61K9/4858A61K31/122A61K31/20A61K31/202A61K31/215A61K31/23A61K31/235A61K31/575A61K31/683A61K31/685A61K45/06C11B3/006A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,543,237
App. No.
16/023,146
Granted
Jan 28, 2020
Kind
B2
Abstract

This invention discloses new krill oil compositions characterized by having high amounts of phospholipids, astaxanthin esters and/or omega-3 contents. The krill oils are obtained from krill meal using supercritical fluid extraction in a two stage process. Stage 1 removes the neutral lipid by extracting with neat supercritical CO 2 or CO 2 plus approximately 5% of a co-solvent. Stage 2 extracts the actual krill oils by using supercritical CO 2 in combination with approximately 20% ethanol. The krill oil materials obtained are compared with commercially available krill oil and found to be more bioeffective in a number of areas such as anti-inflammation, anti-oxidant effects, improving insulin resistances and improving blood lipid profile.

Claims (6)

1. A method of increasing muscle mass in a subject comprising administering to the subject an effective amount of a krill oil composition under conditions such that muscle mass is increased, the krill oil composition comprising from 3% to 10% ether phospholipids w/w of said krill oil; from about 27% to 50% non-ether phospholipids w/w of said krill oil so that the amount of total phospholipids in the composition is from about 30% to 60% w/w of said krill oil; from about 20% to 50% triglycerides w/w of said krill oil, and astaxanthin esters in amount of greater than about 100 mg/kg of said krill oil.

2. The method of claim 1 , wherein the subject is a human subject.

3. The method of claim 1 , wherein protein catabolism is decreased in the subject.

4. The method of claim 1 , wherein the effective amount of krill oil is a daily dose of from 0.2 to 10 grams/day.

5. The method of claim 1 , wherein the effective amount of krill oil is provided in a soft gel capsule.

6. A method of increasing muscle mass in a human subject comprising administering to the human subject from 0.2 to 10 grams/day of a krill oil composition under conditions such that muscle mass is increased, the krill oil composition comprising from 3% to 10% ether phospholipids w/w of said krill oil; from about 27% to 50% non-ether phospholipids w/w of said krill oil so that the amount of total phospholipids in the composition is from about 30% to 60% w/w of said krill oil; from about 20% to 50% triglycerides w/w of said krill oil, and astaxanthin esters in amount of greater than about 100 mg/kg of said krill oil.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 10, 2018
From: AKER BIOMARINE AS
To: AKER BIOMARINE ANTARCTIC AS
Reel/Frame 046303/0689 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 9, 2018
From: BRUHEIM, INGE; TILSETH, SNORRE; MANCINELLI, DANIELE
To: AKER BIOMARINE AS
Reel/Frame 046290/0839 →
Continuity (10)
Continuation 15915439 · Mar 8, 2018
Continuation 15589605 · May 8, 2017
Continuation 15180439 · Jun 13, 2016
Continuation 14020162 · Jun 9, 2013
Continuation 12057775 · Mar 28, 2008
Provisional Application 60920483 · Mar 28, 2007
Provisional Application 60975058 · Sep 25, 2007
Provisional Application 60983446 · Oct 29, 2007
Provisional Application 61024072 · Jan 28, 2008
Related Publication 20180311288A1 · Nov 1, 2018